WARRICK 1624 1624 (Griseofulvin (ultramicrocrystalline) 330 mg)
Pill imprint WARRICK 1624 1624 has been identified as Griseofulvin (ultramicrocrystalline) 330 mg.
Griseofulvin is used in the treatment of tinea pedis; tinea barbae; tinea corporis; tinea capitis; onychomycosis, fingernail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 330 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WARRICK 1624 1624 (Griseofulvin (ultramicrocrystalline) 330 mg)
Griseofulvin (ultramicrocrystalline)
- Imprint:
-
WARRICK
1624 1624 - Strength:
- 330 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Martec Pharmaceuticals Inc
More resources
Griseofulvin (ultramicrocrystalline) is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
